AI assistant
Sending…
Phathom Pharmaceuticals, Inc. — Director's Dealing 2024
Jul 17, 2024
32407_dirs_2024-07-17_cde498a8-0e98-4fb4-b6c8-50d4fc703493.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Phathom Pharmaceuticals, Inc. (PHAT)
CIK: 0001783183
Period of Report: 2024-07-15
Reporting Person: Nabulsi Azmi (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-07-15 | Common Stock | S | 10901 | $11.72 | Disposed | 240421 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3578.93 | Indirect |
| Common Stock | 785700 | Indirect |
Footnotes
F1: Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.
F2: Includes 1,754 shares acquired in January 2024 and 1 share acquired in July 2024 under the Phathom Pharmaceuticals, Inc. employee stock purchase plan
More from Phathom Pharmaceuticals, Inc.
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Regulatory Filings
2026
Mar 27
Director's Dealing
2026
Mar 3
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 12